|
Cancer
Research
|
|
|
Desser L,
Holomanova D, Zavadova E, Pavelka K, Mohr T, Herbacek I
Oral
therapy with proteolytic enzymes decreases excessive TGF-beta levels in human
blood
Cancer Chemother Pharmacol 2001 Jul;47 Suppl:S10-5 (Clinical Study, Abstract)
|
|
Gerard G.
Anticancer
treatment and bromelains
Agressologie 1972;13(4):261-74 (Review Article, Reference)
|
|
Maurer HR
Bromelain:
biochemistry, pharmacology and medical use
Cell Mol
Life Sci. 2001 Aug;58(9):1234-45 (Review Article,
Abstract)
|
|
Taussig SJ,
Batkin S
Bromelain,
the enzyme complex of pineapple (Ananas comosus) and its clinical application. An
update
J Ethnopharmacol 1988
Feb-Mar;22(2):191-203 (Review Article,
Abstract)
|
|
Taussig
SJ, Szekerczes J, Batkin S
Inhibition
of tumour growth in vitro by bromelain, an extract of the pineapple plant (Ananas
comosus)
Planta Med 1985 Dec;(6):538-9 (Cell Culture Study,
Reference)
|
|
Vellini M, Desideri D, Milanese A, Omini C, Daffonchio L,
Hernandez A, Brunelli G
Possible
involvement of eicosanoids in the pharmacological action of bromelain
Arzneimittelforschung 1986;36(1):110-2
(Animal Study, Abstract)
|
|
|
|
Gliomas |
|
|
Tysnes
BB, Maurer HR, Porwol T, Probst B, Bjerkvig R, Hoover F
Bromelain
reversibly inhibits invasive properties of glioma cells
Neoplasia 2001 Nov-Dec;3(6):469-79
Abstract | 
Full
Text | 
Reprint
|
|
|
|
Monograph |
|
|
Barrie Cassileth
and K. Simon Yeung
Bromelain
(Sulphydryl proteolytic enzyme, cysteine-proteinase)
11/07/2002
Memorial Sloar-Kettering Cancer Center (Monograph, HTML Full Text)
|
|
|
|
Non-Neoplastic
Diseases |
|
|
Masson
M.
Bromelain
in blunt injuries of the locomotor system. A study of observed applications in
general practice
Fortschr Med 1995 Jul 10;113(19):303-6
(Clinical Study, Abstract)
|
|
|
|
Non-Nervous
System Tumors |
|
|
Beuth J, Ost
B, Pakdaman A, Rethfeldt E, Bock PR, Hanisch J, Schneider B
Impact
of complementary oral enzyme application on the postoperative treatment results
of breast cancer patients--results of an epidemiological multicentre
retrolective cohort study
Cancer Chemother
Pharmacol 2001 Jul;47 Suppl:S45-54 (Clinical Study, Abstract)
|
|
Eckert K,
Grabowska E, Stange R, Schneider U, Eschmann K, Maurer HR
Effects
of oral bromelain administration on the impaired immunocytotoxicity of
mononuclear cells from mammary tumor patients
Oncol Rep 1999 Nov-Dec;6(6):1191-9 (Clinical Study, Abstract)
|
|
Gujral MS,
Patnaik PM, Kaul R, Parikh HK, Conradt C, Tamhankar CP, Daftary GV
Efficacy
of hydrolytic enzymes in preventing radiation therapy-induced side effects in
patients with head and neck cancers
Cancer Chemother Pharmacol 2001 Jul;47 Suppl:S23-8 (Clinical Study, Abstract)
|
|
Kaul R,
Mishra BK, Sutradar P, Choudhary V, Gujral MS
The
role of Wobe-Mugos in reducing acute sequele of radiation in head and neck
cancers--a clinical phase-III randomized trial
Indian J Cancer 1999 Jun-Dec;36(2-4):141-8 (Clinical Study, Abstract)
|
|
Popiela
T, Kulig J, Hanisch J, Bock PR
Influence
of a complementary treatment with oral enzymes on patients with colorectal
cancers--an epidemiological retrolective cohort study
Cancer Chemother Pharmacol 2001 Jul;47 Suppl:S55-63 (Clinical Study, Abstract)
|
|
